Author： Shaw L.A. Rudin M. Cook N.S.
Publisher： Elsevier
ISSN： 0165-6147
Source： Trends in Pharmacological Sciences, Vol.16, Iss.12, 1995-12, pp. : 401-404
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Pharmacological treatment for prevention of restenosis
By Linde Jacek Strauss Bradley H
Expert Opinion on Emerging Drugs, Vol. 6, Iss. 2, 2001-10 ,pp. :
Access to resources
Recommend
Pharmacological Approaches to the Prevention of Restenosis After Coronary Angioplasty
By Hamon M.
Drugs & Aging, Vol. 13, Iss. 4, 1998-10 ,pp. :
Transglutaminases as Targets for Pharmacological Inhibition
Mini Reviews in Medicinal Chemistry, Vol. 5, Iss. 3, 2005-03 ,pp. :
Clinical and pharmacological experience with etanercept
Expert Opinion on Investigational Drugs, Vol. 8, Iss. 9, 1999-09 ,pp. :